Literature DB >> 2699356

Effects of endothelin on the cardiovascular system and on smooth muscle preparations in different species.

F Lembeck1, M Decrinis, C Pertl, R Amann, J Donnerer.   

Abstract

(1) The actions of porcine endothelin (ET), an endothelium-derived vasoconstrictor peptide, have been investigated in several in vitro smooth and cardiac muscle preparation as well as on the blood pressure of anaesthetized rats and rabbits. (2) In isolated visceral smooth muscles (guinea pig ileum, rat colon and uterus, rabbit jejunum) ET caused a long-lasting contraction which persisted after repeated rinsing. ET did not interfere with the spontaneous phasic activity of the rabbit jejunum or with contractions evoked by histamine or carbachol. (3) ET contracted isolated blood vessels (portal vein of guinea-pig and rat). In isolated perfused organs (rabbit ear, guinea-pig lung, rat mesentery and hindpaw) ET led to a long-lasting vasoconstriction. In the isolated perfused guinea-pig lung ET caused vaso- and bronchoconstriction. (4) ET produced a long-lasting positive inotropic effect in spontaneously beating isolated guinea-pig atria. The positive inotropic action of strophanthin was augmented in the presence of ET. (5) In the isolated perfused guinea-pig and rat hearts the prominent effect of ET was a long-lasting coronary vasoconstriction. (6) Pithed rats responded to i.v. injection of ET with a long-lasting increase in blood pressure. In pentobarbitone anaesthetized rats pretreated either with atropine, with guanethidine plus atropine, or with guanethidine plus atropine plus indomethacin, the long-lasting increase in blood pressure was smaller than in pithed rats whereas the initial short-lasting decrease in blood pressure was more pronounced; in pentobarbitone anaesthetized rabbits endothelin caused bronchoconstriction, a decrease in blood pressure and a pronounced increase in central venous pressure possibly resulting from pulmonary or coronary artery constriction or a combination of both effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2699356     DOI: 10.1007/BF00169684

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Influence of endothelin on systemic arterial pressure and regional blood flow in the cat.

Authors:  R K Minkes; P J Kadowitz
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

2.  Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide.

Authors:  M Yanagisawa; A Inoue; T Ishikawa; Y Kasuya; S Kimura; S Kumagaye; K Nakajima; T X Watanabe; S Sakakibara; K Goto
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor.

Authors:  Y Uchida; H Ninomiya; M Saotome; A Nomura; M Ohtsuka; M Yanagisawa; K Goto; T Masaki; S Hasegawa
Journal:  Eur J Pharmacol       Date:  1988-09-13       Impact factor: 4.432

4.  Endothelin induces potent microvascular constriction.

Authors:  S D Brain; J R Tippins; T J Williams
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

5.  Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo.

Authors:  A N Payne; B J Whittle
Journal:  Eur J Pharmacol       Date:  1988-12-13       Impact factor: 4.432

6.  Cloning and sequence analysis of cDNA encoding the precursor of a human endothelium-derived vasoconstrictor peptide, endothelin: identity of human and porcine endothelin.

Authors:  Y Itoh; M Yanagisawa; S Ohkubo; C Kimura; T Kosaka; A Inoue; N Ishida; Y Mitsui; H Onda; M Fujino
Journal:  FEBS Lett       Date:  1988-04-25       Impact factor: 4.124

Review 7.  Endothelin: an important factor in acute renal failure?

Authors:  J D Firth; P J Ratcliffe; A E Raine; J G Ledingham
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

8.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.

Authors:  K A Hickey; G Rubanyi; R J Paul; R F Highsmith
Journal:  Am J Physiol       Date:  1985-05

9.  Endothelium-dependent contractions in arteries and veins.

Authors:  P M Vanhoutte
Journal:  Blood Vessels       Date:  1987

10.  Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  J Physiol       Date:  1985-07       Impact factor: 5.182

View more
  1 in total

1.  CP-96,345, a non-peptide antagonist of substance P. III. Cardiovascular effects in mammals unrelated to actions on substance P receptors.

Authors:  J Donnerer; U Stark; H A Tritthart; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.